PBIO
PRESSURE BIOSCIENCES
Latest price
As of Oct 30, 2026, 12:19 PM EDT · Market data by Massive
Market cap
—
Volume
25.9K
Previous close
$0.0005
Day range
$0.0002 – $0.0002
Listed
—
Coverage
11 articles
Price performance
Recent trading
Newsroom
Latest PBIO coverage
Pressure BioSciences Announces the Exchange of Over $10 Million of Debt into Equity
Pressure BioSciences, Inc. announced that the Company’s largest shareholder has exchanged over $10 million of senior secured debt into unsecured preferred stock. The debt being converted is comprised of convertible promissory notes, accrued and unpaid interest on all promissory notes issued to the investor since November 2019, plus accrued and unpaid divide
Pressure BioSciences Updates Stakeholders with Solid Progress on Key 2022 Goals: UST Commercial Release, Major Revenue Increase, Continued Financial Position Improvement, and Planned Uplist to National Market
Company Reports Record Instrument Orders in March, Expands BaroFold Platform Services, Builds Strong Demand for Initial UST Tolling Services, and Prepares Foundation for Uplisting SOUTH EASTON, MA / ACCESSWIRE / March 17, 2022 / Pressure BioSciences, Inc. (OTCQB:PBIO) ("PBI" or the "Company"), a leader in the development and sale of broadly enabling, pressur
Ohio State Installs, Commissions New Pilot-Scale Ultra Shear Technology ProcessingEquipment for Preparation of Higher Quality and Safer Liquid Foods and Beverages
Columbus, Ohio, March 3, 2022 – Food processing companies looking for innovative new ways to preserve clean-label liquid food without artificial preservatives will soon have a new option to do so thanks to new technology being developed at The Ohio State University College of Food, Agricultural, and Environmental Sciences (CFAES) in partnership with scientis
Pressure BioSciences Ultra Shear Technology Commercialization Achieves Key Milestone: Production-Scale System Commissioned at Ohio State to Serve Food Industry
Installation of BaroShear MAX UST System in Acclaimed The Ohio State University Food Pilot Plant Will Introduce Global Food Industry to Preparation of Safer, More Nutritious Liquid Foods and Beverages South Easton, MA, January 27, 2022 – Pressure BioSciences, Inc. (OTCQB: PBIO) (“PBI” or the “Company”), a leader in the development and sale of broadly ...
Pressure BioSciences to Participate in FORCE Family Office’s January 20 Webinar: Innovations and Advancements in the $4.6 Billion CBD Market
Company Invites Investors, Analysts, and Advisors to Attend Its Real-Time, Interactive Fireside Chat South Easton, MA, January 19, 2022 – Pressure BioSciences, Inc. (OTCQB: PBIO) (“PBI” and the “Company”), a leader in the development and sale of innovative, broadly enabling, pressure-based instruments, consumables, and services to the worldwide food and beve
$3,500,000 Initial Order for FDA-Registered, Premium Hand Sanitizer Catapults SkinScience Labs, a Pending Accretive Acquisition of Pressure BioSciences, Into the Multi-Billion Dollar Hand Sanitizer Market
SkinScience Labs, Creator of Award-Winning Dr. Denese Skin Care & Anti-Aging Product Lines, Enters Hand Sanitizer Market with Proprietary Formula Developed by Founder Adrienne Denese, MD., Ph.D.
Pressure BioSciences Announces Launch of FDA-Registered Hand Sanitizer as First Product Developed Through Pending Merger Partners
South Easton, MA, May 14, 2020 – Pressure BioSciences, Inc. (OTCQB: PBIO) (“PBI” or the “Company”), a leader in the development and sale of broadly enabling, pressure-based instruments, consumables, and platform technology solutions to the worldwide biotechnology, biotherapeutics, cosmeceuticals, nutraceuticals, and food & beverage industries, today announce
Former L’Oréal President Jim Morrison Appointed as CEO To Lead Availa Bio Upon Merger of Pressure BioSciences, Cannaworx and SkinScience Labs
South Easton, MA, May 7, 2020 – Pressure BioSciences, Inc. (OTCQB: PBIO) (“PBI” or the “Company”), today announced that personal care industry leader Jim Morrison has been appointed to serve as the new CEO of the rebranded public company, Availa Bio, upon completion of the merger with Cannaworx, SkinScience Labs and Pressure BioSciences. As part ...
Pressure BioSciences Announces Planned Name Change to “Availa Bio” Following Completion of Cannaworx and SkinScience Labs Transactions
South Easton, MA, May 5, 2020 – Pressure BioSciences, Inc. (OTCQB: PBIO) (“PBI” or the “Company”), a leader in the development and sale of broadly enabling, pressure-based instruments, consumables, and platform technology solutions to the worldwide biotechnology, biotherapeutics, cosmeceuticals, nutraceuticals, and food & beverage industries, today announced
Pressure BioSciences, Through Cannaworx, Inc., Announces Letter of Intent to Acquire SkinScience Labs, Inc.
South Easton, MA, April 30, 2020 – Pressure BioSciences, Inc. (OTCQB: PBIO) (“PBI” or the “Company”), a leader in the development and sale of broadly enabling, pressure-based instruments, consumables, and platform technology solutions to the worldwide biotechnology, biotherapeutics, cosmeceuticals, nutraceuticals, and food & beverage industries, today announ
Pressure BioSciences Announces Plans to Acquire Cannaworx, Inc.
South Easton, MA, April 29, 2020 – Pressure BioSciences, Inc. (OTCQB: PBIO) (“PBI” or the “Company”), a leader in the development and sale of broadly enabling, pressure-based instruments, consumables, and platform technology solutions to the worldwide biotechnology, biotherapeutics, cosmeceuticals, nutraceuticals, and food & beverage industries, today announ